Mel Krajden
Biographic Data
| ID | 5408128 |
|---|---|
| NAME | Mel Krajden |
| GIVEN NAMES | Mel |
| FAMILY NAME | Krajden |
| SIGNATURE | KRAJDEN M |
| AFFILIATIONS | BC Centre for Disease Control |
| ORCID | 0000-0002-3477-8748 |
| VERIFIED | Yes |
| TOTAL WORKS | 21 |
| TOTAL CITATIONS | 5 |
| AUTHOR COUNT | 21 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2000 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 1 |
Canada’s approach to Sars-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics
Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada
Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada
Objectives. To determine the number of people who inject drugs (PWID) in Canada and the annual coverage of opioid agonist treatment (OAT) and needle-and-syringe provision for PWID. Methods. We estimated the number of PWID in 11 of 13 Canadian provinces and territories in 2011 by using indirect multiplier methods based on provincial and territorial methadone recipient totals and proportion of surveyed PWID receiving methadone. We modeled annual in…
What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada
Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study
Decreasing Hepatitis C Incidence Among a Population With Repeated Tests: British Columbia, Canada, 1993–2011
Objectives. We estimated HCV incidence among individuals who repeatedly underwent anti-HCV testing. Methods. We studied HCV-negative individuals who had at least 2 tests between April 1992 and September 2012 in British Columbia, Canada. We calculated incidence as the number of new infections per 100 person-years at risk. Results. From 1992 to 2012, 323 598 individuals who persistently tested negative and 7490 HCV seroconverters contributed 1 774 …
Expansion of Haart Coverage Is Associated with Sustained Decreases in HIV/Aids Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting
BACKGROUND: There has been renewed call for the global expansion of highly active antiretroviral therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, population-level sustainability of this strategy has not been characterized. METHODS: We used population-level longitudinal data from province-wide registries including plasma viral load, CD4 count, drug resistance, HAART use, HIV diagnoses, AIDS incidence, and HIV-rel…
Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program
The primary predictor of a woman's intention to HPV self-collect for cervical cancer screening was her attitude towards the procedure. From a program planning perspective, these results indicate that education and awareness may be significant contributing factors to improving acceptance of self-collection and subsequently, improving screening attendance rates
Time since last negative HIV test among men who have sex with men and people who use injection drugs in British Columbia, 2006–2011
Mortality among British Columbians testing for hepatitis C antibody
These findings confirm that individuals who test anti-HCV positive have increased mortality related to progressive liver disease, and that a substantial proportion of the mortality is attributable to drug use and risk behaviours/activities associated with HCV acquisition. Mortality reduction in HCV infected individuals will require comprehensive prevention programming to reduce the harms due to behaviours/activities which relate to HCV acquisitio…
Front-line staff-led integrated care
Purpose: To determine the number and type of providers and degree they work together to provide integrated chronic illness care for individuals with hepatitis C care in four small Canadian communities.Theory: A complexity theory-based model of front-line staff initiated partnerships for integrated care guided this descriptive comparative study. Methods:In 2008, front-line staff (nurses) in four hepatitis projects, initiated between 2001 and 2004,…
Uptake, benefits of and barriers to safer crack use kit (SCUK) distribution programmes in Victoria, Canada—A qualitative exploration
Using Centralized Laboratory Data to Monitor Trends in Herpes Simplex Virus Type 1 and 2 Infection in British Columbia and the Changing Etiology of Genital Herpes
Hepatitis C Infection Among Pregnant Women in British Columbia: Reported Prevalence and Critical Appraisal of Current Prenatal Screening Methods
Mumps Virus Detection During an Outbreak in a Highly Unvaccinated Population in British Columbia
HCV co-infection in HIV positive population in British Columbia, Canada
The ability to link BC public health and laboratory HIV and HCV information provided a unique opportunity to explore demographic and risk factors associated with HIV/HCV co-infection. Over half of persons with HIV infection who were tested for HCV were anti-HCV positive; half of these had HCV diagnosed first with HIV identification a median 3.5 years later. This highlights the importance of public health follow-up and harm reduction measures for …
Methadone Use in Relation to Hepatitis C Virus Testing in British Columbia
Hepatitis C and HIV Prevalence Using Oral Mucosal Transudate, and Reported Drug Use and Sexual Behaviours of Youth in Custody in British Columbia
Hepatitis C, Illicit Drug Use and Public Health: Does Canada Really Have a Viable Plan
Diagnostic et test du virus de l’hépatite C
Hepatitis C and HIV Prevalence Using Oral Mucosal Transudate, and Reported Drug Use and Sexual Behaviours of Youth in Custody in British Columbia
Time since last negative HIV test among men who have sex with men and people who use injection drugs in British Columbia, 2006–2011
Hepatitis C, Illicit Drug Use and Public Health: Does Canada Really Have a Viable Plan
Diagnostic et test du virus de l’hépatite C
Hepatitis C, Illicit Drug Use and Public Health: Does Canada Really Have a Viable Plan
Hepatitis C and HIV Prevalence Using Oral Mucosal Transudate, and Reported Drug Use and Sexual Behaviours of Youth in Custody in British Columbia
HCV co-infection in HIV positive population in British Columbia, Canada
The ability to link BC public health and laboratory HIV and HCV information provided a unique opportunity to explore demographic and risk factors associated with HIV/HCV co-infection. Over half of persons with HIV infection who were tested for HCV were anti-HCV positive; half of these had HCV diagnosed first with HIV identification a median 3.5 years later. This highlights the importance of public health follow-up and harm reduction measures for …
Methadone Use in Relation to Hepatitis C Virus Testing in British Columbia
Uptake, benefits of and barriers to safer crack use kit (SCUK) distribution programmes in Victoria, Canada—A qualitative exploration
Using Centralized Laboratory Data to Monitor Trends in Herpes Simplex Virus Type 1 and 2 Infection in British Columbia and the Changing Etiology of Genital Herpes
Hepatitis C Infection Among Pregnant Women in British Columbia: Reported Prevalence and Critical Appraisal of Current Prenatal Screening Methods
Mumps Virus Detection During an Outbreak in a Highly Unvaccinated Population in British Columbia
Front-line staff-led integrated care
Purpose: To determine the number and type of providers and degree they work together to provide integrated chronic illness care for individuals with hepatitis C care in four small Canadian communities.Theory: A complexity theory-based model of front-line staff initiated partnerships for integrated care guided this descriptive comparative study. Methods:In 2008, front-line staff (nurses) in four hepatitis projects, initiated between 2001 and 2004,…
Mortality among British Columbians testing for hepatitis C antibody
These findings confirm that individuals who test anti-HCV positive have increased mortality related to progressive liver disease, and that a substantial proportion of the mortality is attributable to drug use and risk behaviours/activities associated with HCV acquisition. Mortality reduction in HCV infected individuals will require comprehensive prevention programming to reduce the harms due to behaviours/activities which relate to HCV acquisitio…
Expansion of Haart Coverage Is Associated with Sustained Decreases in HIV/Aids Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting
BACKGROUND: There has been renewed call for the global expansion of highly active antiretroviral therapy (HAART) under the framework of HIV treatment as prevention (TasP). However, population-level sustainability of this strategy has not been characterized. METHODS: We used population-level longitudinal data from province-wide registries including plasma viral load, CD4 count, drug resistance, HAART use, HIV diagnoses, AIDS incidence, and HIV-rel…
Women’s intentions to self-collect samples for human papillomavirus testing in an organized cervical cancer screening program
The primary predictor of a woman's intention to HPV self-collect for cervical cancer screening was her attitude towards the procedure. From a program planning perspective, these results indicate that education and awareness may be significant contributing factors to improving acceptance of self-collection and subsequently, improving screening attendance rates
Time since last negative HIV test among men who have sex with men and people who use injection drugs in British Columbia, 2006–2011
Decreasing Hepatitis C Incidence Among a Population With Repeated Tests: British Columbia, Canada, 1993–2011
Objectives. We estimated HCV incidence among individuals who repeatedly underwent anti-HCV testing. Methods. We studied HCV-negative individuals who had at least 2 tests between April 1992 and September 2012 in British Columbia, Canada. We calculated incidence as the number of new infections per 100 person-years at risk. Results. From 1992 to 2012, 323 598 individuals who persistently tested negative and 7490 HCV seroconverters contributed 1 774 …
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: A modelling study
Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets
What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada
Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada
Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada
Objectives. To determine the number of people who inject drugs (PWID) in Canada and the annual coverage of opioid agonist treatment (OAT) and needle-and-syringe provision for PWID. Methods. We estimated the number of PWID in 11 of 13 Canadian provinces and territories in 2011 by using indirect multiplier methods based on provincial and territorial methadone recipient totals and proportion of surveyed PWID receiving methadone. We modeled annual in…
Canada’s approach to Sars-CoV-2 sero-surveillance: Lessons learned for routine surveillance and future pandemics
Medicine (21 works) · Environmental health (14 works) · Internal Medicine (14 works) · Hepatitis C (13 works) · Population (13 works) · Virus (13 works) · Hepatitis C virus (11 works) · Hepatitis C virus research (11 works) · Immunology (10 works) · HIV, Drug Use, Sexual Risk (9 works)